Cure My Disease

Don't miss your cure!

 Log in / Sign up

New turkish questionnaire aims to better measure bladder symptoms in neurological patients

NCT ID NCT07507331

Knowledge-focused Sponsor: Gaziantep Islam Science and Technology University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study is translating and testing a short questionnaire called the Neurogenic Bladder Symptom Score Short Form (NBSS-SF) into Turkish. It will involve 120 adults with spinal cord injury or multiple sclerosis who have bladder problems. The goal is to make sure the Turkish version is accurate and reliable for use in clinics and research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Started

Mar 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will be conducted on patients aged ≥18 years with neurogenic LUTS diagnosed with MS or SCI.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being ≥18 years old * Having a diagnosis of Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) and neurogenic lower urinary tract dysfunction * Being able to read and understand Turkish and have the cognitive ability to independently complete questionnaires * Can be included with any bladder management method (spontaneous voiding, CIC, permanent catheter, condom catheter, reconstruction/diversion etc.) * Volunteering and signing informed consent Exclusion Criteria: * Having an active urinary tract infection (UTI) * Having undergone urological surgery in the last month * Reporting changes in bladder/urinary function between the first and second applications (surgery, UTI, change in bladder medication) * Having a significant recent change in general health status * Having a spinal cord injury (SCI) in the spinal shock phase * Having experienced a relapse of Multiple Sclerosis (MS) within the last 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lower urinary track symptoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis spinal cord injury Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lower urinary track symptoms Multiple sclerosis Neurogenic bladder disorder Spinal cord injury

Contacts and locations

Locations

  • Hacettepe University Hospital, Neurology Outpatient Clinic and Viransehir State Hospital, Urology Outpatient Clinic

    Ankara, Çankaya, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.